InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF – Get Free Report) shares passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $2.30 and traded as high as $5.23. InMed Pharmaceuticals shares last traded at $5.19, with a volume of 4,641 shares traded.
InMed Pharmaceuticals Stock Performance
The firm has a 50-day moving average price of $2.30 and a two-hundred day moving average price of $0.98.
About InMed Pharmaceuticals
InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain.
Further Reading
- Five stocks we like better than InMed Pharmaceuticals
- Stock Market Upgrades: What Are They?
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- What Are Dividend Champions? How to Invest in the Champions
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- What is the Dow Jones Industrial Average (DJIA)?
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for InMed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
